The GLP-1 Timeline: What Actually Happens Month by Month

The honest version of the timeline

Everybody wants the "when will I see it" answer, and I get it — I wanted a calendar too. So here's the honest map, month by month, with the important caveat up front: this is what the research says the average arc looks like, not a promise about your body. Your speed depends on your dose, your starting point, and a hundred things no chart controls. What I can tell you is that the pattern is remarkably consistent, and knowing it kept me from quitting during the boring stretches.

Quick boundary: I don't create accounts or enter medical info for you — I walk the public funnels and read the trial data, then translate it. Some links here earn us a referral fee, and I'll flag my pick; that never changes the honest read. This is education, not medical advice.

Month 1: nothing on the scale, and that's the plan

The thing nobody preps you for is that month one is deliberately underwhelming. These programs start you at a low "starter" dose and step it up slowly on purpose, so your gut has time to adjust — the semaglutide (Wegovy) schedule begins at 0.25 mg a week and climbs in stages over 16 weeks before you ever reach the full maintenance dose³, and tirzepatide (Zepbound) starts at 2.5 mg with a 20-week dose-escalation runway built into its trial².

So if the scale barely twitches the first four weeks, you are not failing — you're doing exactly what the protocol wants. What you may notice is the appetite shift: these drugs slow how fast your stomach empties and quiet the appetite signals, which is why "food noise" tends to fade before the number does anything⁶. Judge month one by "am I tolerating this and is my hunger quieter," not by pounds. I break down the actual day-by-day of these weeks in my first month on a GLP-1, week by week.

Months 2–3: the dose climbs, the scale starts moving

This is where the two things happen at once. Your dose keeps stepping up toward a maintenance level, and the weight loss becomes visible. It's also, honestly, when side effects are most likely — the gastrointestinal stuff (nausea, sometimes constipation or looser stools) clusters during the escalation phase rather than at a steady dose². In the big trials these effects were typically mild-to-moderate and subsided with time¹, but "mild" while parenting is still a lot, so I'd plan lighter meals and protect your hydration through this window.

By around the end of the run-in period, the numbers are real. In the semaglutide maintenance study, people hit roughly 10.6% average weight loss by week 20 — that's the first-few-months payoff, not the finish line⁵. If you want the practical playbook for riding out the nausea months, I keep it in managing GLP-1 side effects.

Months 4–6: the steady-state stretch

Once you're at your maintenance dose, the drama settles and the work becomes consistency. The loss keeps coming, just more gradually — this is the long, unglamorous middle where the weekly shot is routine and the scale trends down in smaller increments. It's genuinely the phase where most people either build the habit or drift, and where I'd tell a friend to stop weighing daily and start weighing the trend.

Which molecule you're on matters for the pace here. In the head-to-head research, tirzepatide's higher doses drove more weight loss than semaglutide — worth knowing if you're still choosing. I lay out that decision, plus the mom-specific angles like breastfeeding timing and birth control, in Zepbound vs Wegovy.

Months 6–12: where the real numbers land

This is the destination the famous statistics describe. Once-weekly semaglutide reached about 14.9% mean body-weight loss at 68 weeks, with roughly half of participants losing 15% or more¹. Higher-dose tirzepatide went further — around 20.9% at 72 weeks on the 15 mg dose². Those are the "before and after" numbers, and notice the timeline: they're measured at 15 to 17 months, not month three. The internet compressed a year-plus of slow progress into a slider, and that's why everyone feels behind.

The loss also isn't linear. It's steepest in the early-to-middle months and flattens as you approach your body's new set point — which is completely normal and not a sign the drug quit. When the scale genuinely stalls, that's its own subject, and I wrote the honest version in hitting a GLP-1 plateau.

The part the timeline charts leave out: it's not a cure

Here's the piece I wish someone had front-loaded for me. The weight loss is a treatment effect, not a reset. In the maintenance trial, people who kept taking semaglutide after week 20 continued losing (another ~7.9% through week 68), while those switched to placebo regained about 6.9%⁵. Translation: this is a chronic-condition medication, and the timeline doesn't have a clean "done." That's not a scare — it's the single most important thing to build your expectations and your budget around. What happens if you come off, I cover in what really happens when you stop a GLP-1.

What I'd actually tell a friend

• Month 1: appetite quiets, scale sits still — that's the plan, don't panic.
• Months 2–3: dose climbs, weight starts dropping, side effects peak — ride it out with smaller meals.
• Months 4–6: steady maintenance dose, gradual loss, build the habit.
• Months 6–12+: the headline numbers land here, then flatten near your new set point.
• Forever-ish: it's a treatment, not a one-and-done — plan for the long game.

If you're picking a program to actually do this with, I'd want one that titrates you carefully, doesn't lock you into a single molecule, and doesn't make you re-start somewhere else if your body wants to switch — that's the kind of thing our Mom-Tested Score methodology rewards, and it's why CoreAge Rx is my #1 pick on the board for women. Your timeline, your history, and your dose belong in a conversation with your own clinician — not a chart.